Product Information
ACEBUTOLOL 400 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.8410 per EA under NDC 62559025601. Its NADAC has been published 198 times since Dec 21, 2022.
FDA first approved this application on Oct 18, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559025601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACEBUTOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074007FDA Approved
10/18/1995
TE Code
AB
On Market Since
7/25/2022
Pharmacological Classes
Price Statistics
The NADAC for ACEBUTOLOL 400 MG CAPSULE has been published 198 times since Dec 21, 2022, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8410 per EA |
|---|---|
| All-time high | $0.9202 (Mar 11, 2026) |
| All-time low | $0.6726 (Jul 17, 2024) |
| 52-week high | $0.9202 |
| 52-week low | $0.8176 |
| Median price | $0.8738 |
| Average price | $0.8468 |
| Largest weekly change | -14.3% (Jul 17, 2024) |
| Weeks tracked | 198 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acebutolol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACEBUTOLOL 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACEBUTOLOL 400 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $0.8410 per EA (NDC 62559025601), effective Sep 30, 2026.
How has the price of ACEBUTOLOL 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACEBUTOLOL 400 MG CAPSULE has declined 5.6%. It has been tracked across 198 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for ACEBUTOLOL 400 MG CAPSULE?
Since Dec 21, 2022, the NADAC for ACEBUTOLOL 400 MG CAPSULE has ranged from a low of $0.6726 (Jul 17, 2024) to a high of $0.9202 (Mar 11, 2026), with a median of $0.8738 per EA.
Are there cheaper alternatives to ACEBUTOLOL 400 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACEBUTOLOL 400 MG CAPSULE, is $0.7260 per EA — about 14% below ACEBUTOLOL 400 MG CAPSULE.
Who manufactures ACEBUTOLOL 400 MG CAPSULE?
ACEBUTOLOL 400 MG CAPSULE (NDC 62559025601) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.